ABOUT 17th_ELSF
​> ATTENDEES​
​> INVESTORS​
​> PRESENTERS​
​> EXHIBITORS​
​> SPONSORS​
​> SUPPORTERS​

+ND Capital
3B Future Health Ventures
4C Biomed Inc.
AAA Family Office
AATec Medical GmbH
AbbVie, Inc.
AC BioScience SA
Accure Therapeutics S.L.
ActiTrexx GmbH
AdBio Partners
AdimaBio Ventures
adMare BioInnovations
Adoram Therapeutics SA
AFK & Partners Asset Management LLC
Aglaia Oncology Funds
AKIGAI
Akribion Genomics AG
Alder Therapeutics AB
Alentis Therapeutics AG
Aliath Bioventures
Almeda Ventures
Alpina Life Science Advisors
AM-Pharma B.V.
Amarna Therapeutics BV
Amplitude Ventures
AMR Action Fund GP GmbH
Andera Partners
Angelini Ventures S.p.A.
Apollo Health Ventures
Araris Biotech AG
ARTHEx Biotech S.L.
Aslan Pharmaceuticals
AstraZeneca
Atamyo Therapeutics SAS
ATGN Consulting
ATHOS
Aukera Therapeutics
Aurealis Therapeutics AG
Avance Basel GmbH
Azafaros Switzerland AG
BaseLaunch
Bergmann zur Hausen & Cie. GmbH
Berlin Partner für Wirtschaft und Technologie GmbH
BERNINA BioInvest Ltd.
Bio Med Gene Ventures
BioGeneration Ventures
BioLizard SA
BioMedPartners AG
BiomedVC AG
Biopôle SA
Bioqube Ventures
BioReperia AB
biosaxony Management GmbH
BIOSTART Consulting GmbH
BioValley Basel & Suterscience, LLC
BioVersys AG
Bioxodes SA
Bird & Bird LLP
BlackRock
Bloomsbury Genetic Therapies
bmp Ventures AG
Boehler Life Science Advice
Boehringer Ingelheim International GmbH
BOHE Angel Fund
Bootstrap Europe
Bpifrance
Bradley Woods & Co. Ltd.
Brainstorm Cell Therapeutics, Inc.
Brandon Capital
Breakpoint Therapeutics GmbH
Breslin AG
Breslin AG & LSFA
BROTHERS & Partners Europe
Business Angels Switzerland
Cantargia AB
Captor Therapeutics S.A.
CARMA FUND Management GmbH
CasInvent Pharma
Catalyze B.V.
Cathay Health
CEBINA Bridge Capital Ltd.
CENPONTS Europe
CH Consulting Group
Cimeio Therapeutics AG
Circio Holding ASA
Claris Ventures
Cohesion Bureau
Convergence Partners AG
Cooley LLP
Corden Pharma International Switzerland LLC
CoreMedic GmbH
Coulter Partners
CrystalsFirst GmbH
Cukierman & Co. Life Sciences
Cureteq AG
Curie.Bio
Cutanos GmbH
DeBere Capital Partners
Debiopharm International SA
Delin Ventures Ltd.
Dementia Discovery Fund - SV Health Investors LLP
DIAMANTE Healthcare Consulting
Digital Networks PLC
Dimericon Therapeutics AG
docdok.health Ltd.
dRx Capital, Novartis
Eczacibasi Pharmaceutical and Industrial Investment Co.
Edison Group
eleva GmbH
Eli Lilly and Company
Encelta AG
Epicelya Therapeutics AG
EpimAb Biotherapeutics
EQT Life Sciences
EraCal Therapeutics Ltd.
ESC Advisors
European Investment Bank
Evaxion Biotech A/S
eversyn
EvlaBio AG
Evoleen AG
Expert Systems, Inc.
F. Hoffmann-La Roche AG
Ferghana Partners, Inc.
Finanz und Wirtschaft / Tamedia
Flerie Invest AB
FluoSphera
Forbion
Forty51 Ventures AG
FoRx Therapeutics AG
Fraser Finance
Fraunhofer IZI (Institute for Cell Therapy and Immunology)
FreeMind Group
Fusix Biotech
FutuRx
GALSER SA
Generation Fund Life Sciences Fund I
Genesis Theranostix Group
Genius Search GmbH & Co. KG
GIBF
Gilde Healthcare
Gimv
Glycostem Therapeutics B.V.
Goethe CVI GmbH
GOLDTRACK Ventures GmbH
GQ Bio Therapeutics GmbH
H Tree Capital
Hadean Ventures
HBM Partners AG
Health Innovation Capital
Heidelberg Pharma AG
Heidi.news
Helmholtz Munich
Hêmera srl
High-Tech Gründerfonds
Hong Kong Exchanges and Clearing Limited
Hong Kong Trade Development Council
Humanetics Corporation
IAG Italian Angels for Growth
ICF Consult Switzerland
Indaco Bio Fund
Indaco Venture Partners SGR S.p.A.
Innovent Biologics
Innovestor Life Science Ltd.

Intermediate Capital Group PLC
Intravacc B.V.
Inversago Pharma Inc.
Invest in Skåne
InvestHK
iOmx Therapeutics AG
IPF Partners
Ipsen
J.P. Morgan Asset Management
Jeito Capital
Johnson & Johnson Innovation – JJDC, Inc.
Johnson & Johnson Innovation LLC
JPMorgan Chase & Co.
Kamari Pharma Ltd.
KBI Biopharma, Inc.
KBio
Kerna Ventures
Kinled Holding Limited
KIZOO Technology Capital GmbH
Kurma Partners
L.E.K. Consulting
Landmark BioVentures AG
Landmark Family Office/Landmark Angels
Leads To Development
Legacy Healthcare
Life Length, S.L.
LIfT BioSciences Ltd.
LMU Munich
Lonza AG
LSA Ventures
LSV Capital Partners
Lynx Financial Hong Kong Ltd.
M Ventures
M&G Advisors GmbH
M2Care
Mabylon AG
Macomics Ltd.
MC Services AG
MC2 Therapeutics A/S
MCE Carrel Avocats SA
Medeor Associates
Medicxi
MEDiSTRAVA
MedNous
Meru Advisors LLC
Mestag Therapeutics Ltd.
MetrioPharm AG
MicroCures, Inc. || Neurevo GmbH || 3Brain AG
Mid Atlantic Bio Angels
Momentum Biotech LLC
MRM Health
MSD
MV BioTherapeutics SA
Nanoligent SL
NatIgGs GmbH
Neuropause Medical
New Science Fund
NewAmsterdam Pharma
Novartis AG
Novartis Venture Fund
Novavax CH GmbH
Novo Holdings A/S
NRW.Venture
NXI Therapeutics AG
NxR Biotechnologies GmbH
Oberland Capital
ObserVa Capital
Ochre Bio
Octopus Ventures
Omega Funds
Oryzon Genomics, S.A.
Oxford BioTherapeutics Ltd.
Oxford Science Enterprises
Panakès Partners SGR SpA
Paul Larue Business Development Consulting
PDC*line Pharma SA
Perseo Pharma AG
Pfizer, Inc.
Phialogics AG
Pictet & Cie SA
Pilatus Biosciences SA
Pioneer Fund
Prevail Partners LLC
Private Equity Investor
Prolevi Bio AB
PROSION Therapeutics
ProteKt Therapeutics Ltd.
Pureos Bioventures
Quadrille Capital
Redalpine Venture Partners AG
Rejuveron Life Sciences AG
Rinri Therapeutics Ltd.
River BioMedics
RNATICS GmbH
Roche Venture Fund
Roivant Sciences GmbH
Rosetta Capital Ltd.
Roy Consulting
RV Invest
Salvina Therapeutics AG
Sanofi
Sapient Therapeutics Ltd.
Schroders Capital
Scius Communications
SDS Optic Inc.
Sea4Us - Biotecnologia e Recursos Marinhos, SA
Secarna Pharmaceuticals GmbH & Co. KG
Second Thought
Seroba Life Sciences
SixPeaks Bio
Sound Bioventures Management AB
SPRIM Global Investments
Staatz Business Development & Strategy
STALICLA SA
StemInov SAS
Stephens Research
Stifel
STIMUNITY SAS
Strategic Transactions Advisory AG
Sunstone Life Science Ventures
Superlab Suisse AG
Swiss Biotech Association
Symeres B.V.
Syncona Investment Management Ltd.
Tagworks Pharmaceuticals BV
Taiho Ventures
TargImmune Therapeutics AG
TauC3 Biologics Limited
TBD Pharmatech OÜ
TheraVenture GmbH
Thermosome GmbH
Tillotts Pharma AG
TILT Biotherapeutics
TME Pharma
TOLREMO Therapeutics AG
Tridek-One
TruVenturo GmbH
Turenne Capital
Turos Capital AG
TVM Capital Life Science
UCB Pharma
University Hospital of Zürich
University of Zurich
Urania Therapeutics
Vaccentis AG
VALANX Biotech GmbH
Valor Management
Vandria SA
Venture Valuation AG
Versant Ventures
Vesalius Biocapital IV
VI Partners AG
Vidac Pharma Holding PLC
VirdisGroup Limited
Vogel BioC
VU Venture Partners
WG Partners
X-Chem, Inc.
XENOTHERA SAS
XGEN Venture SGR S.p.A.
XNK Therapeutics AB
XOventure GmbH
Ymmunobio AG
Ysios Capital Partners S.G.E.I.C., S.A.

Last updated on: 6th of March